Gastroesophageal reflux disease (GERD) affects an estimated 1.03 billion people worldwide, with prevalence ranging significantly by region. Defined as a condition where stomach contents reflux causes troublesome symptoms like heartburn and regurgitation, GERD’s diagnosis often involves endoscopy and reflux monitoring, especially for patients unresponsive to initial treatments. Advanced diagnostic tools such as pH or impedance-pH monitoring and high-resolution esophageal manometry help clinicians confirm GERD and assess for surgical suitability in more severe cases. Evolving treatments include tailored use of proton pump inhibitors (PPIs), novel medical therapies, and endoscopic procedures. Explore the full article for a comprehensive review of diagnostic and management strategies that are helping clinicians better address this pervasive condition.
Trending
- AI-Assisted Colonoscopy and the Diminutive Adenoma Dilemma (Los Angeles Times)
- BE Surveillance, Outpatient ESD, and More (GI & Endoscopy News)
- HHS-OIG Issues Favorable Advisory Opinion for Free Multi-Cancer Detection Supplemental Reports Provided with Medicare-Covered Colorectal Cancer Screening Tests (The National Law Review)
- Physician–researcher’s work yields landmark five-year data for Crohn’s disease drug (Medical Xpress)
- CU Anschutz Biobank Partners with Tech Company to Advance Gut Research and Patient Care (The Regents of the University of Colorado)
- Novant Health adds leading gastroenterology clinicians to its Lowcountry network (Novant Health)
- Solutions Emerging for Post-GLP-1 Weight Regain (Medscape)
- CMS Grants Medicare Coverage for ColoSense®, Expanding Access to Simplified Noninvasive Colorectal Cancer Screening (Business Wire)
